Spoken Alpha
CAPR
CAPRICOR THERAPEUTICS, INC.
Overview
CAPRICOR THERAPEUTICS, INC is a Healthcare company operating in Biotechnology with a $479.1M market cap.
Most recent reported earnings: Q3 FY2026 (Nov 8, 2026).
22 earnings calls indexed on Spoken Alpha.
Behavioral analysis
Management language signature
Disclosures
Investor Relations
Extracted from SEC 10-K filing, 2026-10-04.
Transcripts
Recent earnings calls
Most recent calls indexed for this ticker. Open any call to drill into prepared remarks and Q&A.
- Q2 FY2026Earnings2026-08-13
- Q1 FY2026Earnings2026-05-1220 Q&A exchanges
- Q4 FY2025Earnings2026-03-1217 Q&A exchanges
- Q3 FY2025Earnings2025-11-1028 Q&A exchanges
- Q2 FY2025Earnings2025-08-1826 Q&A exchanges
- Q1 FY2025Earnings2025-05-1321 Q&A exchanges
- Q4 FY2024Earnings2025-03-1921 Q&A exchanges
- Q3 FY2024Earnings2024-11-1313 Q&A exchanges
- Q2 FY2024Earnings2024-08-0814 Q&A exchanges
- Q1 FY2024Earnings2024-05-1310 Q&A exchanges
- Q4 FY2023Earnings2024-02-2914 Q&A exchanges
- Q3 FY2023Earnings2023-11-149 Q&A exchanges
- Q2 FY2023Earnings2023-08-077 Q&A exchanges
- Q1 FY2023Earnings2023-05-1111 Q&A exchanges
- Q4 FY2022Earnings2023-03-1515 Q&A exchanges
- Q3 FY2022Earnings2022-11-1014 Q&A exchanges
- Q2 FY2022Earnings2022-08-1011 Q&A exchanges
- Q1 FY2022Earnings2022-05-104 Q&A exchanges
- Q4 FY2021Earnings2022-03-105 Q&A exchanges
- Q3 FY2021Earnings2021-11-095 Q&A exchanges
- Q2 FY2021Earnings2021-08-1224 Q&A exchanges
- Q1 FY2021Earnings2021-05-1323 Q&A exchanges
History
Earnings history
- Q3 FY20262026-11-08EPS— vs $-0.61—Rev— vs ——EODHD
- Q2 FY20262026-08-12EPS$-0.70 vs $-0.58-20.7%Rev$0 vs ——EODHD
- Q1 FY20262026-05-19EPS$-0.59 vs $-0.48-23.4%Rev$0 vs ——EODHD
- Q4 FY20252026-03-11EPS$-0.62 vs $-0.55-12.7%Rev$0 vs ——EODHD
- Q3 FY20252025-11-09EPS$-0.54 vs $-0.540.0%Rev$0 vs ——EODHD
- Q2 FY20252025-08-10EPS$-0.57 vs $-0.48-18.8%Rev$0 vs ——EODHD
- Q1 FY20252025-05-12EPS$-0.53 vs $-0.32-65.6%Rev$0 vs ——EODHD
- Q4 FY20242025-03-18EPS$-0.16 vs $-0.31+48.4%Rev$11.1M vs ——EODHD
- Q3 FY20242024-11-12EPS$-0.38 vs $-0.34-11.8%Rev$2.3M vs ——EODHD
- Q2 FY20242024-08-06EPS$-0.35 vs $-0.33-6.1%Rev$4.0M vs ——EODHD
- Q1 FY20242024-05-12EPS$-0.31 vs $-0.11-100.0%Rev$4.9M vs ——EODHD
- Q4 FY20232024-02-28EPS$-0.02 vs $-0.09+77.8%Rev$12.1M vs ——EODHD
- Q3 FY20232023-11-13EPS$-0.25 vs $-0.27+7.4%Rev$6.2M vs ——EODHD
- Q2 FY20232023-08-06EPS$-0.29 vs $-0.33+12.1%Rev$3.9M vs ——EODHD
- Q1 FY20232023-05-10EPS$-0.31 vs $-0.32+3.1%Rev$3.0M vs ——EODHD
- Q4 FY20222023-03-14EPS$-0.31 vs $-0.33+6.1%Rev$959.9K vs ——EODHD
- Q3 FY20222022-11-09EPS$-0.26 vs $-0.32+18.8%Rev$1.6M vs ——EODHD
- Q2 FY20222022-08-09EPS$-0.29 vs $-0.25-16.0%Rev$0 vs ——EODHD
- Q1 FY20222022-05-09EPS$-0.32 vs $-0.320.0%Rev$0 vs ——EODHD
- Q4 FY20212022-03-09EPS$-0.26 vs $-0.19-36.8%Rev$244.7M vs ——EODHD
| Period | Reported | EPS actual | EPS consensus | EPS surprise | Revenue actual | Revenue consensus | Rev. surprise | Source |
|---|---|---|---|---|---|---|---|---|
| Q3 FY2026 | 2026-11-08 | — | $-0.61 | — | — | — | — | EODHD |
| Q2 FY2026 | 2026-08-12 | $-0.70 | $-0.58 | -20.7% | $0 | — | — | EODHD |
| Q1 FY2026 | 2026-05-19 | $-0.59 | $-0.48 | -23.4% | $0 | — | — | EODHD |
| Q4 FY2025 | 2026-03-11 | $-0.62 | $-0.55 | -12.7% | $0 | — | — | EODHD |
| Q3 FY2025 | 2025-11-09 | $-0.54 | $-0.54 | 0.0% | $0 | — | — | EODHD |
| Q2 FY2025 | 2025-08-10 | $-0.57 | $-0.48 | -18.8% | $0 | — | — | EODHD |
| Q1 FY2025 | 2025-05-12 | $-0.53 | $-0.32 | -65.6% | $0 | — | — | EODHD |
| Q4 FY2024 | 2025-03-18 | $-0.16 | $-0.31 | +48.4% | $11.1M | — | — | EODHD |
| Q3 FY2024 | 2024-11-12 | $-0.38 | $-0.34 | -11.8% | $2.3M | — | — | EODHD |
| Q2 FY2024 | 2024-08-06 | $-0.35 | $-0.33 | -6.1% | $4.0M | — | — | EODHD |
| Q1 FY2024 | 2024-05-12 | $-0.31 | $-0.11 | -100.0% | $4.9M | — | — | EODHD |
| Q4 FY2023 | 2024-02-28 | $-0.02 | $-0.09 | +77.8% | $12.1M | — | — | EODHD |
| Q3 FY2023 | 2023-11-13 | $-0.25 | $-0.27 | +7.4% | $6.2M | — | — | EODHD |
| Q2 FY2023 | 2023-08-06 | $-0.29 | $-0.33 | +12.1% | $3.9M | — | — | EODHD |
| Q1 FY2023 | 2023-05-10 | $-0.31 | $-0.32 | +3.1% | $3.0M | — | — | EODHD |
| Q4 FY2022 | 2023-03-14 | $-0.31 | $-0.33 | +6.1% | $959.9K | — | — | EODHD |
| Q3 FY2022 | 2022-11-09 | $-0.26 | $-0.32 | +18.8% | $1.6M | — | — | EODHD |
| Q2 FY2022 | 2022-08-09 | $-0.29 | $-0.25 | -16.0% | $0 | — | — | EODHD |
| Q1 FY2022 | 2022-05-09 | $-0.32 | $-0.32 | 0.0% | $0 | — | — | EODHD |
| Q4 FY2021 | 2022-03-09 | $-0.26 | $-0.19 | -36.8% | $244.7M | — | — | EODHD |
Source: EODHD. CAPR reported actuals as published; sparse fields render as —.
Top executives
Executives who appear on this company's earnings calls in our corpus, with role and tenure sourced from SEC filings. Click any name for the full role timeline and call appearance history. Per-executive behavioral deviation metrics are available to research subscribers.
- Linda MarbanCEO6 yr 9 mo22 callsCurrent
- Anthony BergmannCFO6 yr 9 mo7 callsCurrent
- Michael T MaurerCHIEF COMMERCIAL OFFICER6 mono recorded callsCurrent
- Karen KrasneyEVP, GENERAL COUNSEL6 yr 9 mono recorded callsCurrent
- Leland GershellCFO0 mo5 callsFormer
- Xavier AvatCHIEF BUSINESS OFFICER1 mono recorded callsFormer
Peers
Other companies in Healthcare
Sector peers tracked by Spoken Alpha. Each links to the same machine-readable IR surface — earnings calls, executives, and accountability scores.
API
For developers and AI agents
The same data on this page is available as a machine-readable feed via the Spoken Alpha API. One call returns the IR URL, recent transcripts, and accountability scores for CAPR.
$ curl https://api.spokenalpha.com/v1/companies/CAPRFAQ
Frequently asked about CAPR
Where can I find CAPRICOR THERAPEUTICS, INC.'s (CAPR) earnings call transcripts?
Spoken Alpha indexes CAPR's earnings call transcripts at https://spokenalpha.com/companies/CAPR. Each call links to attributed speakers and parsed analyst Q&A. CAPRICOR THERAPEUTICS, INC.'s own investor relations page is at https://www.capricor.com/investors.
When was CAPRICOR THERAPEUTICS, INC.'s most recent earnings call?
CAPRICOR THERAPEUTICS, INC. (CAPR) held its most recent earnings call on 2026-08-13, covering fiscal Q2 2026.
What sector is CAPR in?
CAPRICOR THERAPEUTICS, INC. (CAPR) operates in the Healthcare sector (Biotechnology industry).